Sign in

Private company

Meda AB

Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons5

Swedish healthcare company

Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. At the end of 2014, Meda had 5,202 employees.3 It is part of Mylan.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1995Founded1
  • Industrypharmaceutical industry1
  • HeadquartersSolna Municipality1
  • Websitewww.meda.se
  • Legal formaktiebolag1
  • Listed onOMX AB (MEDA)1
  • Incorporated inSweden6
  • Business addressBox 906, Solna, V7 000006
  • LEI549300SNQNTHQLZQON044
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered addressPipers väg 2A, 170 73 Solna, Sweden4
  • Registered withSwedish Companies Registration Office, 556427-28124

See how the biggest companies compare on our leaderboards

Meda AB is a specialty pharmaceutical company, headquartered in Solna, Sweden. Meda imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. At the end of 2014, Meda had 5,202 employees. Meda's pharmaceuticals are currently sold in more than 150 countries.3

Corporate structure

Meda AB is part of a group headed by Viatris. 252 entities, 53 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Viatris Canonsburg, Pennsylvania, United States
    • Mylan Canonsburg, Pennsylvania, United States
    • Abbex AB Subsidiary · Sweden
    • Acton Pharmaceuticals, Inc. Subsidiary · Delaware, United States
    • Aculys Pharma, Inc. Subsidiary · Japan
    • Agila Australasia Pty Ltd Subsidiary · Australia
    • Agila Specialties Inc. Subsidiary · New Jersey, United States
    • Agila Specialties Investments Limited Subsidiary · United Kingdom
    • Alaven Pharmaceutical LLC Subsidiary · Delaware, United States
    • Alphapharm Pty. Ltd. Subsidiary · Australia
    • ALVP Holdings, LLC Subsidiary · Delaware, United States
    • American Triumvirate Insurance Company Subsidiary · Vermont, United States
    • Arcana Arzneimittel GmbH Subsidiary · Austria
    • BGP Pharma ULC Subsidiary · Canada
    • BGP Products AB Subsidiary · Sweden
    • BGP Products Operations GmbH Subsidiary · Switzerland
    • BGP Products S.r.l. Subsidiary · Romania
    • BGP Products, Unipessoal, LDA Subsidiary · Portugal
    • Delcor Asset Corporation Subsidiary · Delaware, United States
    • Denco Asset, LLC Subsidiary · Delaware, United States
    • Deogun Manufacturing, LLC Subsidiary · Delaware, United States
    • Dey Limited Partner LLC Subsidiary · Delaware, United States
    • Dey, Inc. Subsidiary · Delaware, United States
    • DPT Laboratories, Ltd. Subsidiary · Texas, United States
    • EMD, Inc. Subsidiary · Delaware, United States
    • Erste Madaus Beteiligungs GmbH Subsidiary · Germany
    • and 217 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0). Each entity in the chart links to its source.

Subsidiaries and ownership

Parent company

From Wikidata.1

Acquisitions

In 2005, Meda bought German pharmaceutical brand Viatris GMBH from

Advent International for €750million ($926 million).

On 20 July 2007, Meda announced an $800 million cash-and-stock deal to buy the New Jersey–based pharmaceutical company MedPointe from a group of U.S. investors. MedPointe bought the diagnostics and drug businesses of Carter-Wallace in 2001, with the consumer product line going to Church & Dwight. The deal was completed on 22 August with Meda entering the US market. The new shareholders in Meda are The Carlyle Group, The Cypress Group LLC, and other US investors, who had a combined shareholding in Meda of approximately 7%.

In 2014, Meda acquired the Italian firm Rottapharm Madaus in order to add consumer health products to their portfolio. Meda explored in 2015 the possibility of divesting its United States division, Meda Pharmaceuticals, to raise funds for expansion in other areas.

From Wikipedia’s article on Meda AB, shared under CC BY-SA 4.0.7

Employees over time

  • 20145,2001

Timeline

  1. 1995Founded Founded1

SEC filer profile

How Meda AB is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARMeda AB2
  • CIK0001411795
  • Incorporated inSweden2
  • Business addressBox 906, solna, v7 000002
  • Phone46-8-630-19-002
  • On EDGAR sinceSep 5, 20072
  • Filings3 in all: CB (2), REGDEX (1)2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7